Integrated Diagnostics Holdings (LSE:IDHC) Insider Ownership: 71.34 % (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:IDHC Integrated Diagnostics Holdings PLC LSE:IDHC
47 GF Score
Price $0.55
GF Value $0.60
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Integrated Diagnostics Holdings Insider Ownership?

Integrated Diagnostics Holdings LSE:IDHC +5.06% 47 Insider Ownership is 71.34 % as of Aug. 30, 2026. GuruFocus rates LSE:IDHC with a GF Score™ of 47/100 and a GF Value™ of $0.60 (Fairly Valued). The stock has 6 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Integrated Diagnostics Holdings's insider ownership is 71.34%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Integrated Diagnostics Holdings's Institutional Ownership is 7.48%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Integrated Diagnostics Holdings's Float Percentage Of Total Shares Outstanding is 0.00%.

Integrated Diagnostics Holdings Insider Ownership Historical Data

* Premium members only.

The historical data trend for Integrated Diagnostics Holdings's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrated Diagnostics Holdings Insider Ownership Chart

Integrated Diagnostics Holdings Historical Data

The historical data trend for Integrated Diagnostics Holdings can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 27.99 27.99 27.99 27.99 27.99 27.99 27.99 49.67 71.34 71.34
LSE:IDHC
47GF Score
Integrated Diagnostics Holdings PLC LSE:IDHC
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integrated Diagnostics Holdings Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 71.34 % mean?
Integrated Diagnostics Holdings (LSE:IDHC) has a Insider Ownership of 71.34 % as of Aug. 30, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Integrated Diagnostics Holdings and its competitors.
Is Integrated Diagnostics Holdings' Insider Ownership too high?
Integrated Diagnostics Holdings' current Insider Ownership is 71.34 %. Overall, Integrated Diagnostics Holdings has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Integrated Diagnostics Holdings' Insider Ownership compare to TMO and DHR?
Integrated Diagnostics Holdings' Insider Ownership of 71.34 % can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Diagnostics & Research company?
A good Insider Ownership depends on the Medical Diagnostics & Research industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Integrated Diagnostics Holdings and its competitors. Integrated Diagnostics Holdings's current Insider Ownership is 71.34 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integrated Diagnostics Holdings (LSE:IDHC) is currently considered Fairly Valued. The stock's GF Value™ is $0.60, compared to a current price of $0.55 — trading 8.3% below its estimated fair value. The current Insider Ownership is 71.34 %. Integrated Diagnostics Holdings' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Integrated Diagnostics Holdings (LSE:IDHC), the current Insider Ownership is 71.34 % as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integrated Diagnostics Holdings (LSE:IDHC) Overvalued in 2026?

Based on GuruFocus' analysis, Integrated Diagnostics Holdings stock appears to be undervalued. The current stock price of $0.55 is trading 8.3% below its estimated GF Value™ of $0.60. GuruFocus considers Integrated Diagnostics Holdings to be Fairly Valued.

Key valuation signals for LSE:IDHC:

  • Insider Ownership: 71.34 %
  • GF Value™: $0.60 vs. price of $0.55 (8.3% below fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the LSE:IDHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integrated Diagnostics Holdings Business Description

Address 12 Castle Street, St Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
47GF Score

Get the complete analysis for LSE:IDHC

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.55
Price
$0.60
GF Value